tm
Seeing Is Believing
tm
Seeing Is Believing
PHAR is currently covered by 1 analysts with an average price target of $37. This is a potential upside of $26.48 (251.71%) from yesterday's end of day stock price of $10.52.
Pharming Group NV's activity chart (see below) currently has 32 price targets and 25 ratings on display. The stock rating distribution of PHAR is 100% BUY.
Highest price target for PHAR is $37, Lowest price target is $37, average price target is $37.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 22-Sep-2026. First documented stock forecast 16-Feb-2023.
Currently out of the existing stock ratings of PHAR, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Feb-2023
$37
$26.54 (253.73%)
$37
7 days ago
(22-Sep-2026)
0/20 (0%)
$25.74 (228.60%)
Buy Since 28-Mar-2023
$39
$28.54 (272.85%)
$30
1 years 6 months 15 days ago
(14-Mar-2025)
0/3 (0%)
$30.05 (335.75%)
Which analyst most recently updated their price target on PHAR (Pharming Group NV)?
Which analyst has the most public recommendations on PHAR (Pharming Group NV)?
Which analyst is the currently most bullish on PHAR (Pharming Group NV)?
Which analyst is the currently most reserved on PHAR (Pharming Group NV)?
